Device Week, Sept. 28, 2017 – Social Media And Health; New Heart Player On Horizon
In this edition of Device Week, find out more about the increasing body of research into social media’s role in health care and what makes acute heart failure therapy specialist Magenta Medical a particularly interesting investment bet.
You may also be interested in...
The Dutch company received the US FDA's breakthrough device designation in 2018 for the surgical patch.
Johnson & Johnson previously agreed to acquire TachoSil but terminated the transaction due to regulatory hurdles.
Emmanuel Ligner, president and CEO of Cytiva, talks to In Vivo about how the company will dramatically increase its manufacturing capabilities over the next five years, at a price tag of $500m.